Literature DB >> 32828386

Aiming for 100% Local Control in Locally Advanced Cervical Cancer: The Role of Complex Brachytherapy Applicators and Intraprocedural Imaging.

Christen R Elledge1, Anna W LaVigne1, Rohini K Bhatia1, Akila N Viswanathan2.   

Abstract

The use of brachytherapy for the treatment of gynecologic malignancies, particularly cervical cancer, has a long and rich history that is nearly as long as the history of radiation oncology itself. From the first gynecologic brachytherapy treatments in the early 20th century to the modern era, significant transformation has occurred driven largely by advancements in technology. The development of high-dose rate sources, remote afterloaders, novel applicators, and 3-dimensional image guidance has led to improved local control, and thus improved survival, solidifying the role of brachytherapy as an integral component in the treatment of locally advanced cervical cancer. Current research efforts examining novel magnetic resonance imaging sequences, active magnetic resonance tracking, and the application of hydrogel aim to further improve local control and reduce treatment toxicity.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32828386     DOI: 10.1016/j.semradonc.2020.05.002

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  2 in total

1.  Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience.

Authors:  Xiaojun Ren; Yingli Fu; Zhongshan Liu; Xia Lin; Ling Qiu; Yunfeng Li; Hanyang Li; Yuqi Bai; Tiejun Wang
Journal:  Front Oncol       Date:  2022-07-19       Impact factor: 5.738

2.  Tumor size before image-guided brachytherapy is an important factor of local control after radiotherapy for cervical squamous cell carcinoma: analysis in cases using central shielding.

Authors:  Kotaro Yoshio; Hiroki Ihara; Kazuhiro Okamoto; Etsuji Suzuki; Takeshi Ogata; Soichi Sugiyama; Keiichiro Nakamura; Shoji Nagao; Hisashi Masuyama; Takao Hiraki
Journal:  J Radiat Res       Date:  2022-09-21       Impact factor: 2.438

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.